Antibodies capable of specifically binding to tl1a and their use

Abstract

This description relates to antibodies that bind specifically to TL1A and uses thereof, in particular to antibodies that bind specifically to TL1A or antigen-binding fragments thereof, nucleic acids encoding the antibodies or antigen-binding fragments thereof, vectors containing the nucleic acids, and host cells containing the nucleic acids or vectors. Pharmaceutical compositions comprising the antibodies and methods of treatment using the antibodies are also provided.